Noam Krantz

Noam Krantz is the Senior Vice President of Corporate Development at Guardant Health, a prominent precision oncology company. Prior to assuming his current executive position, he built an extensive track record as a senior leader at Johnson & Johnson, where he served as Vice President and Chief Operating Officer. During his extended tenure within the broader Johnson & Johnson corporate organization, Krantz also operated as a dedicated healthcare investor for Johnson & Johnson Innovation and held key operational roles at the medical device subsidiary Ethicon Inc. Throughout his professional career, he has specialized in managing complex corporate operations, executing strategic investments, and scaling health technology enterprises across highly competitive markets. Krantz currently focuses on advancing corporate development initiatives, identifying strategic partnerships, and driving long-term commercial growth within the global biotechnology and healthcare innovation sectors.